ai and lung cancer screenings
Lung cancer is the deadliest cancer in the U.S. An estimated 127,070 Americans will die from lung cancer in 2023.1 Early detection of lung cancer through low-dose computed tomography (LDCT) screening has been shown to significantly reduce lung cancer mortality in high-risk populations and is currently recommended annually by the U.S.
5 min read
Chi-Fu Jeffrey Yang, MD, Thoracic Surgery
lung preservation

The landscape around lung transplantation continues to evolve rapidly. Improved surgical techniques and advances in perioperative care complement an ever-expanding array of devices.

4 min read
Brandon A. Guenthart, MD, Stanford Medicine

Overall survival rates of esophageal cancer have risen in the past 50-plus years, from 5% in 1970 to 22% in 2023. Yet, no comprehensive guidelines addressing multidisciplinary management of esophageal cancer that incorporate input from surgeons, radiation oncologists, and medical oncologists have been available, until now. 

The Society of Thoracic Surgeons, American Society for Radiation Oncology, and American Society of Clinical Oncology have co-authored the first comprehensive guideline on the management of esophageal cancer. Published today in The Annals of Thoracic Surgery, the guideline addresses key clinical subject areas pertinent to the care of patients with locally advanced, resectable thoracic esophageal cancer. 

The guideline delivers recommendations for the use of induction chemotherapy, optimal radiation dose, value and timing of esophagectomy, use of chemotherapy vs. chemoradiotherapy before surgery, approach and extent of lymphadenectomy, and the value of adjuvant therapy after resection.

“These comprehensive guidelines address areas critical for standardizing and improving care and outcomes for esophageal cancer patients,” says study investigator Stephanie Worrell, MD, clinical associate professor and thoracic section chief at the University of Arizona in Tucson. “The recommendations are based on a comprehensive review of innovations and advancements in the most recent literature.”

Nov 2, 2023
1 min read
Using largest U.S. Database, study in low-risk patients reveals 5-year survival rate of 93%
Oct 17, 2023

For the first time, The Society of Thoracic Surgeons joined the Korean Society for Thoracic and Cardiovascular Surgery (KSTCVS) in their presentation of the Heart Valve Disease Forum (HVDF), an annual conference that delivers the latest developments on the basis, cause, diagnosis, treatment, and future of valve disease.

Heart Valve Disease Forum in Seoul

The forum, held September 15-16, 2023, in Dragon City, Yongsan, Seoul, was led by the President of the HVDF, Dr. Kyung Hwan Kim, and organized by co-program directors Dr. Joon Bum Kim of Asan Medical Center of Ulsan College of Medicine and Dr. S. Chris Malaisrie of Northwestern University, who commented “STS was thrilled to partner with the KSTCVS on this international event, highlighting transpacific expertise on valves.”

Dr. Kim remarked, “By co-hosting the forum with STS, we brought together the world’s top scholars in related fields for discussion and achieved the best conference experience.”

More than 300 surgeons, residents, and other medical students attending the conference heard from luminary surgeons and professors on today’s hottest topics impacting the specialty, including TAVI, innovative SAVR, and endocarditis, and trained on surgical techniques in wet labs. “The dynamic, case-based discussions and interactive wet labs with skilled faculty inspired the next generation of cardiac surgeons," said Dr. Malaisrie.

Dr. Thomas MacGillivray, president of STS, delivered several talks, including one on “Crisis Management in the Operating Room and Surgeon Leadership.”

At this year’s conference, particular emphasis was placed on connecting young surgeons responsible for the future of heart valve surgery with proven STS surgeon leaders through a mentor-mentee program. It was an exclusive opportunity for early career attendees to gain invaluable guidance on navigating their career paths and overcoming challenges from leaders.

“The heart valve symposium was a wonderful success and a historical event that stands out among the meeting’s 30-year history,” said Dr. Kim. “Our Korean colleagues agreed that collaborating with STS was the best thing in terms of excellence of lectures, one-to-one teaching in the wet lab, an exciting mentorship program, and beautiful times spent outside of the conference room.”

Oct 10, 2023
2 min read

A panel of leaders in cardiothoracic surgery will explore the cost of patient safety relative to the effects on education, how public reporting of patient safety is often confusing to patients, and how expected patient safety results may lead to disproportionate investments and difficult prioritization decisions.

Topics will include: 

1 hr. 2 min.
STS recently endorsed and is actively working to advance several key bills in Congress to improve access to lung cancer screenings.  
3 min read
Haley Brown, STS Advocacy

July 25, 2023, Chicago, Ill… The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess the risk of adult cardiac surgery operations.

Jul 25, 2023
Discussions on valuable research and important clinical findings with the goal of improving data collection and patient outcomes.
Event dates
Sep 26–29, 2023
Be the voice of the cardiothoracic surgery specialty in Washington, DC
Event dates
Oct 17–18, 2023
Washington, D.C.
Recently the General Thoracic (GTSD) and Congenital Heart (CHSD) surgery components joined the STS Adult Cardiac Surgery Database in powering "Best Hospitals" rankings and practice-changing research.
Apr 17, 2023